Nonalcoholic Fatty Liver Disease: Biomarkers Support Decisions Around Pharmacological Intervention

Hepatology - United States
doi 10.1002/hep.28866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley